-
KEYNOTE-826 : Controlled trial of combination therapy in patients with persistent, recurrent, or metastatic cervical cancer
See trial results -
KEYNOTE-164: Single-arm open-label studies in patients with MSI-H, including mismatch repair deficient (dMMR),colorectal cancer who have received prior therapy
See trial resultsKEYNOTE-177: Controlled trial in colorectal carcinoma patients previously untreated for metastatic MSIH or dMMR CRC
See trial results -
KEYNOTE-146: Open-label trial in patients with endometrial carcinoma that is not MSI-H or dMMR
See trial resultsKEYNOTE-775: Controlled trial of combination therapy in patients with advanced endometrial carcinoma, who have received at least one prior platinum based chemotherapy regimen in any setting
See trial results -
KEYNOTE-158: Single-arm open-label studies in patients with MSI-H, including mismatch repair deficient (dMMR), cancer who have received prior therapy
See trial results -
KEYNOTE-590: Controlled trial of combination therapy in esophageal carcinoma patients naïve to treatment
See trial results -
KEYNOTE-048: Controlled trial of first-line monotherapy or combination therapy in HNSCC
See trial results -
KEYNOTE-204: Controlled trial in patients with relapsed or refractory cHL
See trial results -
KEYNOTE-170: Open‐label study in patients with relapsed or refractory PMBCL
See trial results -
KEYNOTE-002: Controlled trial in melanoma patients previously treated with ipilimumab
See trial resultsKEYNOTE-006: Controlled trial in melanoma patients naïve to treatment with ipilimumab
See trial resultsKEYNOTE-054: Placebo‐controlled trial for the adjuvant treatment of patients with completely resected stage III melanoma
See trial resultsKEYNOTE-716: Placebo-controlled trial for the adjuvant treatment of patients with completely resected Stage IIB or IIC melanoma
See trial results -
KEYNOTE-010: Controlled trial in NSCLC patients previously treated with chemotherapy
See trial resultsKEYNOTE-024: Controlled trial of NSCLC patients naïve to treatment
See trial resultsKEYNOTE-042: Controlled trial of NSCLC patients naïve to treatment
See trial resultsKEYNOTE-189: Controlled trial of combination therapy in non-squamous NSCLC patients naïve to treatment
See trial resultsKEYNOTE-407: Controlled trial of combination therapy in squamous NSCLC patients naïve to treatment
See trial results -
KEYNOTE-564: Placebo-controlled trial for the adjuvant treatment of adult patients with resected RCC
See trial resultsKEYNOTE-426: Controlled trial of combination therapy with axitinib in patients with advanced or metastatic RCC naïve to treatment
See trial resultsKEYNOTE-581: Controlled trial of combination therapy with lenvatinib in patients with advanced or metastatic RCC with no prior systemic therapy
See trial results -
KEYNOTE-355: Controlled study of combination therapy in locally recurrent unresectable or metastatic TNBC patients naïve to treatment
See trial resultsKEYNOTE-522: Controlled study of neoadjuvant and adjuvant treatment of patients with early‐stage TNBC.
See trial results -
KEYNOTE-045: Controlled trial in urothelial carcinoma patients previously treated with platinum-containing chemotherapy
See trial resultsKEYNOTE-052: Open-label trial in urothelial carcinoma patients ineligible for cisplatin-containing chemotherapy
See trial resultsKEYNOTE-057: Open-label trial in BCG-unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
See trial results